Background: |
The products of the Polycomb group (PcG) of genes are necessary for the maintenance of transcriptional repression of a number of important developmental genes, including the homeotic genes. RYBP is a member of the mammalian polycomb complex. RYBP (RING1- and YY1-binding protein) interacts specifically with the E2F2 and E2F3 family members, dependent on the marked box domain in these proteins. YY1 and RYBP, in combination with either E2F2 or E2F3, can stimulate Cdc6 promoter activity synergistically, at G1/S of the cell cycle. RYBP also complexes with both RING1 proteins (RING1 and RING1B) and with M33, two mutually interacting sets of proteins of the mammalian Polycomb complex. RING1 binds RYBP and M33 through the same C-terminal domain, whereas the RYBP-M33 interaction takes place through an M33 domain not involved in binding. RYBP is widely expressed with highest levels in lymphoid tissues and placenta. |
Applications: |
WB |
Name of antibody: |
RYBP |
Immunogen: |
Fusion protein of human RYBP |
Full name: |
RING1 and YY1 binding protein (RYBP) |
Synonyms: |
AAP1; DEDAF; YEAF1; APAP-1 |
SwissProt: |
Q8N488 |
WB Predicted band size: |
25 kDa |
WB Positive control: |
Hela, SVT2, A549, COS7, Jurkat, MDCK cell lysates |
WB Recommended dilution: |
500-2000 |